Some studies in mice have shown that low expression of PD-1/PD-L1 or anti-PD-1/PD-L1 treatment exacerbated atherosclerotic plaque formation and accelerated the immune process of CHD (7, 8). Here, CD274 is linked to coronary artery disorder.